Sarah A. O'Dowd

Insider Reports History

Location
Fremont, CA
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Sarah A. O'Dowd
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sarah A. O'Dowd:

Company Role Class Num Shares Value Price $ Report Date Ownership
ICHOR HOLDINGS, LTD. Director Ordinary Shares, par value $0.0001 28,325 $1,241,485 $43.83 15 May 2024 Direct
Protagonist Therapeutics, Inc Director Common Stock 7,825 $683,433 $87.34 02 Jan 2026 Direct
Protagonist Therapeutics, Inc Director Stock Option (right to buy) 3,762 02 Jan 2026 Direct

Insider Reports Filed by Sarah A. O'Dowd

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PTGX Protagonist Therapeutics, Inc 02 Jan 2026 2 $0 4 Director 06 Jan 2026, 19:39
PTGX Protagonist Therapeutics, Inc 02 Jan 2025 2 $0 4 Director 06 Jan 2025, 18:10
ICHR ICHOR HOLDINGS, LTD. 15 May 2024 1 $0 4 Director 17 May 2024, 16:18
PTGX Protagonist Therapeutics, Inc 02 Jan 2024 1 $0 4 Director 04 Jan 2024, 20:17
ICHR ICHOR HOLDINGS, LTD. 18 May 2023 1 $0 4 Director 22 May 2023, 17:58
PTGX Protagonist Therapeutics, Inc 16 Jan 2023 1 $0 4 Director 18 Jan 2023, 19:00
PTGX Protagonist Therapeutics, Inc 26 May 2022 1 $0 4 Director 27 May 2022, 16:02
ICHR ICHOR HOLDINGS, LTD. 24 May 2022 1 $0 4 Director 26 May 2022, 17:44
PTGX Protagonist Therapeutics, Inc 27 May 2021 1 $0 4 Director 28 May 2021, 18:50
ICHR ICHOR HOLDINGS, LTD. 11 May 2021 1 $0 4 Director 14 May 2021, 17:42